Your browser doesn't support javascript.
loading
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib.
Bouché, Olivier; Cesne, Axel Le; Rios, Maria; Chaigneau, Loic; Italiano, Antoine; Duffaud, Florence; Lecomte, Thierry; Arsène, Dominique; Manfredi, Sylvain; Aparicio, Thomas; Remy, Stéphane; Isambert, Nicolas; Collard, Olivier; Priou, Frank; Bertucci, François; Sambuc, Roland; Bisot-Locard, Ségolene; Bourges, Olivier; Chabaud, Sylvie; Blay, Jean-Yves.
Afiliación
  • Bouché O; Department of Digestive Oncology, University Hospital, Reims, France.
  • Cesne AL; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France.
  • Rios M; Department of Medical Oncology, Institut de Cancérologie de Lorraine-Alexis Vautrin, Nancy, France.
  • Chaigneau L; Department of Medical Oncology, Centre J. Minjoz Universitary Hospital Center, Besançon, France.
  • Italiano A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Duffaud F; Department of Medical Oncology, La Timone University Hospital, Marseille and Aix -Marseille University (AMU), Marseille, France.
  • Lecomte T; Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital Trousseau, Tours, France.
  • Arsène D; Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital Caen Normandy, Caen, France.
  • Manfredi S; Department of Gastroenterology Oncology, University Hospital Dijon, Dijon, France.
  • Aparicio T; Department of Medical Oncology, University Hospital Saint Louis, Paris, France.
  • Remy S; Department of Medical Oncology, Clinique Paulmy, Bayonne, France.
  • Isambert N; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Collard O; Department of Medical Oncology, Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France.
  • Priou F; Department of Medical Oncology, Les Oudairies hospital CHD Vendée, La Roche sur Yon, France.
  • Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Sambuc R; Department of Public Health, La Conception Hospital, Marseille, France.
  • Bisot-Locard S; Oncology Business Unit, Novartis Pharma S.A.S., Rueil-Malmaison, France.
  • Bourges O; Oncology Business Unit, Novartis Pharma S.A.S., Rueil-Malmaison, France.
  • Chabaud S; Biostatistics Unit, Centre Léon Bérard, Lyon, France.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
PLoS One ; 13(9): e0204117, 2018.
Article en En | MEDLINE | ID: mdl-30226855
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Francia